rumpus008

For artists that focused on limited edition NFT artwork to date, Open Editions can be a way to establish a broader collector base with the potential of growing engagement with future drops. rumpus008.substack.com/p/open-nft-edi…

@rkawong66 @Dave46217976 @rt7683 @ATLnsider LOL ... agreed. Ryan is projecting a fraud narrative and parroting the @statnews talking points regarding $NWBO. He's that Nigerian Prince not yet caught in the Twitter spam filter. Pure garbage.

@Dave46217976 @rt7683 @ATLnsider OS, OS, OS, OS, OS, OS, OS, OVERALL SURVIVAL Ryan is trying his best 'smoke and mirrors' routine. Obviously he/she is a plant (or even paid) FUDster from a competitor or one of the Defendants. Get GBM and worry about anything but Overall Survival and Quality of Life. $NWBO

It was good to hear $NWBO is in talks with CRL to update their CDMO agreement to manufacture #DCVax-L for North America out of Memphis. Also, MIA approval by MHRA for commercial manufacturing is imminent, then MAA regulatory submissions will be made to multiple regulators.

We got @DillonFrancis in the building tonight 🎶

@Nwbofactcheck @flaskworks @All4Nwbo @metacollectiveG Your opinion doesn't matter either, "facts". You don't shape opinion here.

@flaskworks @All4Nwbo @metacollectiveG Just because that’s what you see on Twitter every day doesn’t mean the majority of shareholders believe in your sentiment. I think most believe in the science and great potential this product has. Not solely in mgmt execution which is basically non existent

$NWBO delivered as expected...nothing ...lame management got their payday ...and can sit on awesome treatment longer and can kick the can down the road

@rago_carlo Agreed, biggest news from yesterday, IMO, and a real surprise. Looking forward to your perspective, Carlo.

This is a critical revelation, IMO. More on this later. $NWBO

@paramount @justinkeister5 Approval, revenue, partnership/JV/BO will drive an increase in stock price. Not sure how you define "massive".

@justinkeister5 I’m honestly curious what you think will drive massive share increase.

$NWBO 2023 goals are to increase my share position by > 100k. Thank you market manipulation for your assistance in helping me reach my goals.

@rumpus008 I see you tuned in to the share holder meeting. I'll wake you up when they actually make progress towards approval. Hope you're comfortable.

$NWBO share holder meeting seems to confirm what I’ve been trying to say for over a year. There is not some secret package for immediate approval. There is still quite a long timeline before FDA or EU regulators even start to look at Dc-Vax. 1/N

And all of the shameless pumpers of $NWBO, who claim to be well informed either on the science or the business side, are clearly, conveniently, wearing blinders on the risks. Maybe because for them, the risk isn’t the same as someone who buys on the open market.

@SnackBioTech @rago_carlo

Speaking of reminders, could @rago_carlo remind me if his compensation is still tied to the performance of $NWBO shares?

@COLOlending @HarrisonWind I will keep watching. The highlights I saw from Sac Game 1 seemed like it. Definitely not overwhelmed in previous seasons. He has to get game time ... or they should trade him. He's good enough for the NBA.

@rumpus008 @HarrisonWind Whenever he gets time, he seems overwhelmed.

Zeke Nnaji's six fouls in 15 minutes last night. One of the softest foul outs I've seen.

@COLOlending @HarrisonWind I disagree after watching him the last two seasons. He needs PT, though.

@HarrisonWind He might be a bust. Agree?

@glen_bwrhr42 @Frank_Goldwater 😂

@Nwbofactcheck @metacollectiveG If management was responding with PR to every single communication with an RA, it would contribute to the smear campaign ... this is known. If one hasn't studied history, one would make this argument. Linda Powers & $NWBO should keep quiet until RA approval, JV/BO &/or revenue

@metacollectiveG $NWBO could not disagree more. Misinformation spreads much faster than one would think. Each day more biased information is being spread by large entities. If the company came out and put their foot down confirming/shouting their victory, it would squash the doubt being spread

Holidays are upon us big money is likely on vacation. Assuming no news it’s a tactful move for dilution to mitigate the sell off and manipulation that will occur. The sad part is each day there are new large names/articles out for blood and bashing $NWBO silence doesn’t help

@TiltMyBrain @AlMusella @MartinvdenBent Lot's of effort being made by oncology professionals tied to $NVCR (that know better) to help set AF up as committing negligence instead of committing fraud.

@AlMusella @MartinvdenBent What do you expect from a chemo/ radiation researcher??? Bias anyone??? $NWBO

@AlMusella @MartinvdenBent Dr. van der Bent clearly knows enough to submit a better paper. Dr Liau has said, the data is the data, and acknowledges the trial design issues. Not clear why Dr. V would put his reputation on the line like this. Flipper shares interesting points here: investorshub.advfn.com/boards/read_ms…

@MartinvdenBent Why do you say ‘post hoc’ when it clearly says in the publication “This is the first SAP that has been submitted for the Trial, and it is being submitted prior to Data Lock and unblinding of the study results.” What does ‘post hoc’ mean to you?

@metacollectiveG @EANOassociation @NeuroOnc @OncoAlert Makes sense. AF blocked everyone to claim he hasn't had any interactions with longs. There's enough proof otherwise, despite his efforts to delete. His strategy is that he's a bad journalist that doesn't know better.

@rumpus008 @EANOassociation @NeuroOnc @OncoAlert I’m sure the lawyers for his employer have asked him to do these things. It doesn’t change the fact DCVax will be approved, it just provides him with cover for his written words. His collusion however, could be exposed and that’s his bigger problem

Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination (DCVax-L) in glioblastoma: breakthrough or fata morgana? academic.oup.com/neuro-oncology… #btsm #DCVax #glioblastoma @NeuroOnc @OncoAlert

@metacollectiveG @EANOassociation @NeuroOnc @OncoAlert Curious if this is a legal tactic. AF now has several "expert" sources to point to that strangely, despite the evidence, parrot his concerns with the $NWBO trial. How could one risk their professional integrity by submitting this critique with shallow appreciation for the facts?

@EANOassociation @NeuroOnc @OncoAlert It’s stunning that people who hold high positions can’t have the decency to actually read the entire article and the supplements showing the SAP before making such stupid statements. This kind of biased egg head work is sloppy and it makes one wonder their true reasoning

@ATLnsider $NWBO mgmt def needs to stay focused! Also thinking these responses from drs who seem like they haven't read the $NWBO JAMA peer reviewed article are sharing a clipped POV to protect AF, @statnews & financial connections to John Henry. Dr. van den Bent's article is a legal tactic

$NWBO is close to getting #DCVax-L approved in US, UK, Canada, Germany & rest of EU. There are forces with conflicting financial interests. $NWBO must stay focused on getting regulatory approvals & don’t worry about naysayers & detractors. As Dr. Liau said “the data is the data”.

When Real Betis fans threw thousands of stuffed animals on the pitch for children in need last December ❤️

I want to call on @BernieSanders @katieporteroc @SenWarren to look into @citsecurities and @statnews to investigate the naked short selling of the #DCVax NWBO Dr. Linda Liau saved my life with a personalized vaccine 💉 I have a G.B.M and I’ve survived 8 yrs w/out a recurrence.

@FlemmingBruce It's strange that Dr Perry acknowledges DCVax-L impact to you on Twitter in Nov, retweeted $NVCR marketing material a few days later & now this. Dr. Perry should point to his tweets that hold Stupp & $NVCR accountable for their flawed study that overstates Optune benefit.

$NWBO No matter how hard you and Optune players like Matt Williams try to discredit a 73 authors peer revied JAMA journal, by obviously not understanding basic english, that post-hoc was never an issue and FDA asked for crossover ...